Contact Us

Cell and gene therapy player CBM plots expansion, 2,000 new hires with funding from South Korean partner

CBM's new 1 million square foot Cell Therapy Manufacturing facility
November 21, 2021

The Center for Breakthrough Medicines (CBM), a CDMO founded in 2019, is getting financial backing from South Korean financial group SK Inc. to expand its manufacturing capacity.

The two companies didn’t disclose a dollar amount, but CBM said it will use the funding to build out its manufacturing suite as well as support operations, research and lab capabilities.

Read full story

Contact Us Now